Cargando…
Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies
Cardiovascular disease remains the leading cause of death in the United States, and cardiopulmonary bypass is a cornerstone in the surgical management of many related disease states. Pathophysiologic changes associated both with extracorporeal circulation and shock can beget a syndrome of low system...
Autores principales: | Barnes, Theresa J, Hockstein, Maxwell A, Jabaley, Craig S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328055/ https://www.ncbi.nlm.nih.gov/pubmed/32647575 http://dx.doi.org/10.1177/2050312120935466 |
Ejemplares similares
-
Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass
por: Pasero, D., et al.
Publicado: (2020) -
Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass
por: Muhammad, Rizal, et al.
Publicado: (2022) -
The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia
por: Papazisi, Olga, et al.
Publicado: (2020) -
Vasoplegia: A Review
por: Ratnani, Iqbal, et al.
Publicado: (2023) -
The Durability of Intravenous Hydroxocobalamin in Vasoplegia
por: Blaha, Madeline, et al.
Publicado: (2023)